wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q28253501-A0FB573C-3B04-4149-9BEF-D2CEB00E97B6
Q28253501-A0FB573C-3B04-4149-9BEF-D2CEB00E97B6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28253501-A0FB573C-3B04-4149-9BEF-D2CEB00E97B6
Antibodies to watch in 2015
P2860
Q28253501-A0FB573C-3B04-4149-9BEF-D2CEB00E97B6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28253501-A0FB573C-3B04-4149-9BEF-D2CEB00E97B6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
895c5fe39854b96471e84a1ab641902665754492
P2860
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial.